Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Osteoporosis
Interventions
DRUG

zoledronic acid

5 mg zoledronic acid administered in a single 15 minute IV

Trial Locations (1)

44195

The Cleveland Clinic Foundation, Cleveland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

The Cleveland Clinic

OTHER